Thyroseq genomic classifier tests
Ended Awarded Last action
- Contract number
- 36C24625N0027
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $62,000
Award facts
- Contract value 100% obligated
- $62,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Port Chester, NY 10573, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$38,000 | |
| Original award | $100,000 |
About this award
Cytopath Biopsy Lab Inc., operating as Cblpath, was awarded a $62,000 firm fixed-price blanket purchase agreement (BPA) call by Veterans Integrated Service Network 6 (VISN 6) on October 1, 2024, for ThyroSeq genomic classifier tests. The contract, which extends through September 30, 2025, represents a call order against the company's existing $2.25 million BPA vehicle with VISN 6 awarded in October 2025. No small business set-aside was utilized for this award. The services will be performed in Port Chester, New York, and involve the delivery of specialized molecular diagnostic testing for thyroid nodule analysis using Cblpath's proprietary ThyroSeq technology, which assesses genetic mutations to evaluate cancer risk and support clinical decision-making for veteran patients.
Cblpath has established itself as the primary provider of ThyroSeq molecular diagnostic testing across the Department of Veterans Affairs, maintaining a substantial contracting portfolio with over 50 federal awards since 2021. The company's federal customer base extends beyond the VA to include the Defense Health Agency and the National Institutes of Health, with contract values ranging from $2,000 to $2.31 million. Cblpath currently holds nine indefinite delivery vehicles with the VA across multiple VISNs, all structured as firm fixed-price contracts without set-aside designations, reflecting the company's competitive positioning as a specialized provider of advanced genomic sequencing and molecular diagnostic laboratory services to the federal healthcare system.
Quick answers
Who was awarded contract 36C24625N0027?
36C24625N0027 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24625N0027 worth?
The government has obligated $62,000 on 36C24625N0027.
Is contract 36C24625N0027 an order under another contract?
Yes. 36C24625N0027 is a BPA call under 36C24624A0017, a blanket purchase agreement.
Was contract 36C24625N0027 competed?
The extent of competition for 36C24625N0027 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award